[Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].

Abstract

alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.